Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
41.39B | 39.34B | 33.51B | 36.80B | 29.55B | 28.26B | Gross Profit |
8.96B | 8.83B | 8.01B | 8.46B | 5.97B | 6.09B | EBIT |
5.53B | 5.65B | 4.63B | 5.48B | 3.25B | 3.59B | EBITDA |
6.67B | 6.81B | 5.79B | 6.72B | 4.39B | 4.91B | Net Income Common Stockholders |
3.44B | 3.57B | 3.05B | 5.86B | 2.13B | 1.86B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
5.85B | 4.91B | 5.09B | 6.09B | 4.95B | 4.72B | Total Assets |
198.54B | 201.93B | 193.40B | 175.51B | 169.42B | 148.52B | Total Debt |
135.26B | 140.28B | 135.74B | 119.57B | 120.48B | 100.04B | Net Debt |
129.41B | 135.37B | 130.65B | 113.47B | 115.53B | 95.32B | Total Liabilities |
156.08B | 159.30B | 153.26B | 137.63B | 135.95B | 116.49B | Stockholders Equity |
41.90B | 42.49B | 39.78B | 37.55B | 33.34B | 31.89B |
Cash Flow | Free Cash Flow | ||||
0.00 | -3.33B | -14.93B | -1.41B | -19.89B | -1.28B | Operating Cash Flow |
0.00 | -3.25B | -14.87B | -1.30B | -19.88B | -1.27B | Investing Cash Flow |
0.00 | -334.00M | -903.00M | 3.62B | -81.00M | -2.00M | Financing Cash Flow |
0.00 | 3.41B | 14.73B | -1.16B | 20.19B | 665.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥27.27B | 7.39 | 5.67% | 17.40% | 17.97% | ||
78 Outperform | ¥12.25B | 8.21 | 2.71% | 2.12% | -6.76% | ||
76 Outperform | ¥781.64B | 9.06 | 4.15% | 1.67% | 18.48% | ||
76 Outperform | ¥10.28B | 7.97 | 4.21% | 6.95% | 4.92% | ||
70 Outperform | ¥30.81B | 6.77 | 2.56% | -22.59% | 26.95% | ||
67 Neutral | ¥351.53B | 7.65 | 3.95% | -4.25% | -4.22% | ||
66 Neutral | $4.51B | 12.22 | 5.40% | 3.63% | 4.14% | -12.01% |